Latest News about GILD
Recent news which mentions GILD
3 Stocks Retirees Should Absolutely Love
July 29, 2023
From Motley Fool
Trial Setback For Gilead Sciences: Shuts Late-Stage Magrolimab/Azacitidine Combo Study In Type Of Blood Cancer
July 24, 2023
Tickers
GILD
From Benzinga
From Benzinga
AMC shares surge after judge rejects APE conversion plan, Tesla stock slips on downgrade and other stocks on the move
July 24, 2023
From MarketWatch
From Motley Fool
From InvestorPlace
From Motley Fool
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
From Benzinga
From Motley Fool
FDA Approves Gilead's Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment
July 14, 2023
Tickers
GILD
From Benzinga
7 Tech Stocks to Watch on July 14
July 12, 2023
From InvestorPlace
From Benzinga
From Benzinga
Is Johnson & Johnson Stock a Buy Now?
July 09, 2023
From Motley Fool
The 3 Best Biotech Stocks to Buy In July
July 05, 2023
From InvestorPlace
From Benzinga
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
From Motley Fool
Gilead's Chronic Hepatitis Delta Infection Treatment Shows Sustained Efficacy, Safety Profile At Two Years
June 23, 2023
Tickers
GILD
From Benzinga
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.